Keyphrases
Idiopathic Pulmonary Fibrosis
100%
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
100%
ED-SCLC
66%
Median Overall Survival
16%
Lung Carcinogenesis
16%
Median Progression-free Survival
16%
Retrospective Observational Study
16%
Systemic Chemotherapy
16%
Chemotherapy Efficacy
16%
Progression-free Survival
16%
Nursing and Health Professions
Small Cell Lung Cancer
100%
Fibrosing Alveolitis
100%
Overall Survival
33%
Progression Free Survival
33%
Distant Metastasis
16%
Lung Carcinogenesis
16%
Pharmacology, Toxicology and Pharmaceutical Science
Small Cell Lung Cancer
100%
Fibrosing Alveolitis
100%
Progression Free Survival
33%
Distant Metastasis
16%
Lung Carcinogenesis
16%